PAK2 promotes proliferation, migration, and invasion of lung squamous cell carcinoma through the LIMK1/cofilin signaling pathway

Abstract

Although p21-activated kinase 2 (PAK2) is an essential serine/threonine protein kinase, its role in the progression of lung squamous cell carcinoma (LUSC) has yet to be fully understood. We analyzed PAK2 mRNA levels, DNA copy numbers, and protein levels by quantitative reverse transcription-PCR and immunohistochemical staining in both human LUSC tissues and adjacent normal tissues. Then, we performed colony formation assays, cell counting kit-8 assays, Matrigel invasion assays, wound healing assays, and xenograft models in nude mice to investigate the functions of PAK2 in LUSC progression. We demonstrated that PAK2 mRNA levels, DNA copy numbers, and protein levels were upregulated in human LUSC tissues, compared with adjacent normal tissues. Additionally, higher PAK2 expression was associated with poorer prognosis in LUSC patients. In the in vitro study, we found that PAK2 promoted cell growth, migration, invasion, epithelial-mesenchymal transition, and cell morphology regulation in LUSC cells. Mechanistically, PAK2 promoted tumor cell proliferation, migration, and invasion by regulating actin dynamics through the LIMK1/cofilin signaling pathway. Our findings indicate that the PAK2/LIMK1/cofilin signaling pathway may serve as a potential clinical marker and therapeutic target for LUSC.

Keywords

PAK2 / lung squamous cell carcinoma / LIMK1 / cofilin

Fundings

This work was supported by the National Natural Science Foundation of China (Grant No. 32300615), and the Nanjing Medical Science and Technique Development Foundation (Grant No. JQX19010).

Acknowledgments

None.

References

[1] Dizon DS, Krilov L, Cohen E, et al. Clinical cancer advances 2016: annual report on progress against cancer from the American Society of Clinical Oncology[J]. J Clin Oncol, 2016, 34(9): 987-1011. doi: 10.1200/JCO.2015.65.8427

[2] Novello S, Barlesi F, Califano R, et al. Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up[J]. Ann Oncol, 2016, 27(suppl 5): v1-v27. doi: 10.1093/annonc/mdw326

[3] Chen JW, Dhahbi J. Lung adenocarcinoma and lung squamous cell carcinoma cancer classification, biomarker identification, and gene expression analysis using overlapping feature selection methods[J]. Sci Rep, 2021, 11(1): 13323. doi: 10.1038/s41598-021-92725-8

[4] Yuan B, Zhang R, Hu J, et al. WDR1 promotes cell growth and migration and contributes to malignant phenotypes of non-small cell lung cancer through ADF/cofilin-mediated actin dynamics[J]. Int J Biol Sci, 2018, 14(9): 1067-1080. doi: 10.7150/ijbs.23845

[5] Whale A, Hashim FN, Fram S, et al. Signalling to cancer cell invasion through PAK family kinases[J]. Front Biosci (Landmark Ed), 2011, 16(3): 849-864. https://pubmed.ncbi.nlm.nih.gov/21196207/

[6] Rane CK, Minden A. P21 activated kinase signaling in cancer[J]. Semin Cancer Biol, 2019, 54: 40-49. doi: 10.1016/j.semcancer.2018.01.006

[7] Senapedis W, Crochiere M, Baloglu E, et al. Therapeutic potential of targeting PAK signaling[J]. Anticancer Agents Med Chem, 2016, 16(1): 75-88. https://pubmed.ncbi.nlm.nih.gov/26081410/

[8] Jang I, Jeon BT, Jeong EA, et al. Pak1/LIMK1/cofilin pathway contributes to tumor migration and invasion in human non-small cell lung carcinomas and cell lines[J]. Korean J Physiol Pharmacol, 2012, 16(3): 159-165. doi: 10.4196/kjpp.2012.16.3.159

[9] Tan X, Tong L, Li L, et al. Loss of Smad4 promotes aggressive lung cancer metastasis by de-repression of PAK3 via miRNA regulation[J]. Nat Commun, 2021, 12(1): 4853. doi: 10.1038/s41467-021-24898-9

[10] Varshney P, Dey CS. P21-activated kinase 2 (PAK2) regulates glucose uptake and insulin sensitivity in neuronal cells[J]. Mol Cell Endocrinol, 2016, 429: 50-61. doi: 10.1016/j.mce.2016.03.035

[11] Gao C, Ma T, Pang L, et al. Activation of P21-activated protein kinase 2 is an independent prognostic predictor for patients with gastric cancer[J]. Diagn Pathol, 2014, 9: 55. doi: 10.1186/1746-1596-9-55

[12] Zhang Y, Lin P, Zou JY, et al. MiR-216a-5p act as a tumor suppressor, regulating the cell proliferation and metastasis by targeting PAK2 in breast cancer[J]. Eur Rev Med Pharmacol Sci, 2019, 23(6): 2469-2475. doi: 10.26355/eurrev_201903_17394

[13] Siu MKY, Wong ESY, Chan HY, et al. Differential expression and phosphorylation of Pak1 and Pak2 in ovarian cancer: effects on prognosis and cell invasion[J]. Int J Cancer, 2010, 127(1): 21-31. doi: 10.1002/ijc.25005

[14] Li X, Wen W, Liu K, et al. Phosphorylation of caspase-7 by p21-activated protein kinase (PAK) 2 inhibits chemotherapeutic drug-induced apoptosis of breast cancer cell lines[J]. J Biol Chem, 2011, 286(25): 22291-22299. doi: 10.1074/jbc.M111.236596

[15] Misra UK, Deedwania R, Pizzo SV. Binding of activated α₂-macroglobulin to its cell surface receptor GRP78 in 1-LN prostate cancer cells regulates PAK-2-dependent activation of LIMK[J]. J Biol Chem, 2005, 280(28): 26278-26286. doi: 10.1074/jbc.M414467200

[16] Prunier C, Prudent R, Kapur R, et al. LIM kinases: cofilin and beyond[J]. Oncotarget, 2017, 8(25): 41749-41763. doi: 10.18632/oncotarget.16978

[17] Luo M, Wang Z, Wu J, et al. Effects of PAK1/LIMK1/cofilin-mediated actin homeostasis on axonal injury after experimental intracerebral hemorrhage[J]. Neuroscience, 2022, 490: 155-170. doi: 10.1016/j.neuroscience.2022.03.009

[18] Pollard TD, Borisy GG. Cellular motility driven by assembly and disassembly of actin filaments[J]. Cell, 2003, 112(4): 453-465. doi: 10.1016/S0092-8674(03)00120-X

[19] Yang N, Higuchi O, Ohashi K, et al. Cofilin phosphorylation by LIM-kinase 1 and its role in Rac-mediated actin reorganization[J]. Nature, 1998, 393(6687): 809-812. doi: 10.1038/31735

[20] Ye DZ, Field J. PAK signaling in cancer[J]. Cell Logist, 2012, 2(2): 105-116.

[21] Bagheri-Yarmand R, Mazumdar A, Sahin AA, et al. LIM kinase 1 increases tumor metastasis of human breast cancer cells via regulation of the urokinase-type plasminogen activator system[J]. Int J Cancer, 2006, 118(11): 2703-2710. doi: 10.1002/ijc.21650

[22] Davila M, Frost AR, Grizzle WE, et al. LIM kinase 1 is essential for the invasive growth of prostate epithelial cells: implications in prostate cancer[J]. J Biol Chem, 2003, 278(38): 36868-36875. doi: 10.1074/jbc.M306196200

[23] Yoshioka K, Foletta V, Bernard O, et al. A role for LIM kinase in cancer invasion[J]. Proc Natl Acad Sci U S A, 2003, 100(12): 7247-7252. doi: 10.1073/pnas.1232344100

[24] Cheung AHK, Hui CHL, Wong KY, et al. Out of the cycle: Impact of cell cycle aberrations on cancer metabolism and metastasis[J]. Int J Cancer, 2023, 152(8): 1510-1525. doi: 10.1002/ijc.34288

[25] Flamini MI, Fu X, Sanchez AM, et al. Effects of raloxifene on breast cancer cell migration and invasion through the actin cytoskeleton[J]. J Cell Mol Med, 2009, 13(8B): 2396-2407. doi: 10.1111/j.1582-4934.2008.00505.x

[26] Borensztajn K, Peppelenbosch MP, Spek CA. Coagulation Factor Xa inhibits cancer cell migration via LIMK1-mediated cofilin inactivation[J]. Thromb Res, 2010, 125(6): e323-e328. doi: 10.1016/j.thromres.2010.02.018

[27] Konakahara S, Ohashi K, Mizuno K, et al. CD29 integrin- and LIMK1/cofilin-mediated actin reorganization regulates the migration of haematopoietic progenitor cells underneath bone marrow stromal cells[J]. Genes Cells, 2004, 9(4): 345-358. doi: 10.1111/j.1356-9597.2004.00726.x

[28] Namme JN, Bepari AK, Takebayashi H. Cofilin signaling in the CNS physiology and neurodegeneration[J]. Int J Mol Sci, 2021, 22(19): 10727. doi: 10.3390/ijms221910727

[29] Zhang L, Luo J, Wan P, et al. Regulation of cofilin phosphorylation and asymmetry in collective cell migration during morphogenesis[J]. Development, 2011, 138(3): 455-464. doi: 10.1242/dev.046870

[30] Zeng R, Zheng C, Chen W, et al. Rho GTPases in cancer radiotherapy and metastasis[J]. Cancer Metastasis Rev, 2020, 39(4): 1245-1262. doi: 10.1007/s10555-020-09923-5

[31] Dai Y, Gao X, Liu D, et al. The role of Rho GTPase family in cochlear hair cells and hearing[J]. Neural Regen Res, 2023, 18(10): 2167-2172. doi: 10.4103/1673-5374.369101

[32] Cao S, Chen Y, Ren Y, et al. GLUT1 biological function and inhibition: research advances[J]. Future Med Chem, 2021, 13(14): 1227-1243. doi: 10.4155/fmc-2021-0071

[33] Szablewski L. Expression of glucose transporters in cancers[J]. Biochim Biophys Acta, 2013, 1835(2): 164-169. doi: 10.1016/j.bbcan.2012.12.004

[34] Zhou Z, Li Y, Chen S, et al. GLUT1 promotes cell proliferation via binds and stabilizes phosphorylated EGFR in lung adenocarcinoma[J]. Cell Commun Signal, 2024, 22(1): 303. doi: 10.1186/s12964-024-01678-8